Murcko scaffold
Ring system with 3 rings and 16 atoms
42 chemicals on CompoundList share this ring system.
- Rings
- 3
- Scaffold atoms
- 16
- Chemicals
- 42
- With full pages
- 8
Scaffold SMILES
O=c1[nH]cnc2c1[nH]c(=O)n2C1CCCO1
A Bemis-Murcko scaffold is what remains of a molecule when every side chain is removed: the rings and the chains that link them. Chemicals that share a scaffold often belong to the same compound series, which helps when you look for analogues, alternative suppliers or related building blocks.
![Murcko scaffold O=c1[nH]cnc2c1[nH]c(=O)n2C1CCCO1](/scaffold/OCGHRGCNCAPGDV-UHFFFAOYSA-N/structure.svg)
Computed from the structures of the chemicals listed here. Stereo and charges are removed before the scaffold is taken.
Chemicals with this scaffold
Open one to see its structure, properties and suppliers.
Showing 1 to 42 of 42 chemicals
![1,2-Diamino-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7H-purine-6,8-dione chemical structure, C10H14N6O6, CAS 19029-70-0](/s/SIXZCFPRAGPNFK-UHFFFAOYSA-N.svg)
1,2-Diamino-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7H-purine-6,8-dione
CAS 19029-70-0C10H14N6O6
2-Amino-1-methyl-9-pentofuranosyl-7,9-dihydro-1H-purine-6,8-dione
CAS 27964-07-4C11H15N5O6
![2-Amino-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,7-dimethylpurine-6,8-dione chemical structure, C12H17N5O6, CAS 27963-78-6](/s/DZBCTDQUESAKQL-UHFFFAOYSA-N.svg)
2-Amino-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,7-dimethylpurine-6,8-dione
CAS 27963-78-6C12H17N5O6
![1,2-Diamino-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-methylpurine-6,8-dione chemical structure, C11H16N6O6, CAS 27963-77-5](/s/LBADDCIXRKMOKD-UHFFFAOYSA-N.svg)
1,2-Diamino-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-methylpurine-6,8-dione
CAS 27963-77-5C11H16N6O6
8-Oxo-dGTP
CAS 139307-94-1C10H16N5O14P3
![2-Amino-9-[3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-7,9-dihydro-1H-purine-6,8-dione chemical structure, C10H13N5O6, CAS 686300-05-0](/s/FPGSEBKFEJEOSA-UHFFFAOYSA-N.svg)
2-Amino-9-[3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-7,9-dihydro-1H-purine-6,8-dione
CAS 686300-05-0C10H13N5O6
8-Hydroxyguanosine
CAS 3868-31-3C10H13N5O6
Loxoribine
CAS 121288-39-9C13H17N5O6
2-Amino-9-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-7-methyl-1H-purine-6,8(7H,9H)-dione
CAS 917567-94-3C11H15N5O5
7-Methyl-8-oxoguanosine
CAS 28007-87-6C11H15N5O6
8-Hydroxy-2'-deoxyguanosine
CAS 88847-89-6C10H13N5O5
7-Propyl-8-oxoguanosine
CAS 126092-77-1C13H19N5O6
2'-Deoxy-7,8-dihydro-8-oxo-5'-guanylic acid
CAS 127027-50-3C10H14N5O8P
8-Hydroxyguanosine triphosphate
CAS 21238-36-8C10H16N5O15P3
8-Oxo-GMP
CAS 21082-26-8C10H14N5O9P
8-Oxoguanosine 2'-phosphate
CAS 85775-41-3C10H14N5O9P
Poly-8-oxyinosinic acid
CAS 83614-18-0C10H13N4O9P
8-Hydroxyguano-sine
CAS 2390368-04-2C10H13N5O6
Inosine, 2-chloro-7,8-dihydro-7-methyl-8-oxo-
CAS 114039-29-1C11H13ClN4O6
7,8-Dihydro-8-oxo-2'-deoxyinosine
CAS 105879-26-3C10H12N4O5
9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-hydroxy-7H-purin-8(9H)-one
CAS 63699-77-4C10H12N4O6
8-Hydroxy-N2-isobutryl-2'-deoxyguanosine
CAS 136859-76-2C14H19N5O6
8-Hydroxy-2'-deoxyguanosine-15N5
CAS 569649-11-2C10H13N5O5
1-Amino-3'-deoxy-7,8-dihydro-8-oxoguanosine
CAS 2389988-59-2C10H14N6O5
- 7-(Butyn-2-yl)-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)guanine2389988-33-2C14H17N5O6
- 7-n-Butyl-7,8-dihydro-8-oxo-9-(|A-D-xylofuranosyl)guanine2389988-45-6C14H21N5O6
- TLR7agonist122389988-47-8C14H19N5O8
- TLR7 agonist 112389988-36-5C14H17N5O8
- TLR7 agonist 92389988-38-7C14H17N5O7
- 7-Propargyl-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)guanine2389988-31-0C13H15N5O6
- 7,8-Dihydro-8-oxo-7-propargyl-3'-deoxyguanosine2389988-54-7C13H15N5O5
- TLR7 agonist 102389988-34-3C14H19N5O6
- 7-n-Propyl-7,8-dihydro-8-oxo-9-(|A-D-xylofuranosyl)guanine2389988-44-5C13H19N5O6
- 7,8-Dihydro-8-oxo-7-propargyl-3'-deoxy-3'-fluoro-xylo-guanosine2389988-56-9C13H14FN5O5
- 7-Ethyl-7,8-dihydro-8-oxo-9-(|A-D-xylofuranosyl)guanine2389988-43-4C12H17N5O6
- 2-Amino-9-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-enyl-1H-purine-6,8-dione2389988-25-2C13H17N5O6
- 3'-Deoxy-2',5'-di-O-acetyl-8-hydroxyguanosine2389988-72-9C14H17N5O7
- Orb19086012389988-21-8C10H14N6O6
- 1 suppliersCompound 27 [WO2019226977A1]2389988-55-8C13H14FN5O5
- Purine-6,8(1H,9H)-dione, 9-ribofuranosyl-6138-13-2C10H12N4O6
- Inosine 5'-(tetrahydrogen triphosphate), 2'-deoxy-7,8-dihydro-8-oxo-(9CI)508219-93-0C10H15N4O14P3
- 7,8-Dihydro-8-oxo-7-propargylguanosine2763084-98-4C13H15N5O6
Related scaffolds
Same ring framework with different atoms or bond orders
c1ncc2ncn(C3CCCO3)c2n1474 chemicals![Scaffold O=c1[nH]cnc2c1ncn2C1CCCO1](/scaffold/JBXHFRZBULGPSC-UHFFFAOYSA-N/structure.svg)
O=c1[nH]cnc2c1ncn2C1CCCO1141 chemicals
O=C1NC(=S)SC1=C1C(=O)Nc2ccccc2171 chemicals
c1ncc2ccn(C3CCCO3)c2n147 chemicals![Scaffold S=c1[nH]cnc2c1ncn2C1CCCO1](/scaffold/DXIBRFHEZZOPFH-UHFFFAOYSA-N/structure.svg)
S=c1[nH]cnc2c1ncn2C1CCCO121 chemicals![Scaffold c1ccc2c(-c3cscn3)c[nH]c2c1](/scaffold/WMACHIODVOSLNK-UHFFFAOYSA-N/structure.svg)
c1ccc2c(-c3cscn3)c[nH]c2c119 chemicals
C1=CC(n2cnc3cncnc32)CC113 chemicals![Scaffold c1ccc2c(-c3nnc[nH]3)c[nH]c2c1](/scaffold/KLBYNKNNBXGMQF-UHFFFAOYSA-N/structure.svg)
c1ccc2c(-c3nnc[nH]3)c[nH]c2c19 chemicals![Scaffold O=c1[nH]cnc2c1ccn2C1CCCO1](/scaffold/KMILJNWZZSWZDI-UHFFFAOYSA-N/structure.svg)
O=c1[nH]cnc2c1ccn2C1CCCO19 chemicals![Scaffold O=c1[nH]c(=O)c2ncn(C3CCCO3)c2[nH]1](/scaffold/OQOJIIPEEFHULF-UHFFFAOYSA-N/structure.svg)
O=c1[nH]c(=O)c2ncn(C3CCCO3)c2[nH]19 chemicals![Scaffold c1ccc2c(-c3cnco3)c[nH]c2c1](/scaffold/AHGVTWJUSLDERM-UHFFFAOYSA-N/structure.svg)
c1ccc2c(-c3cnco3)c[nH]c2c18 chemicals![Scaffold O=c1[nH]cnc2scc(-c3cccs3)c12](/scaffold/LFUBTAOTPHKKOS-UHFFFAOYSA-N/structure.svg)
O=c1[nH]cnc2scc(-c3cccs3)c128 chemicals